In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
FDA approves ZOMETA for bone complications of cancer
Prostate Cancer Drug Abarelix Shows Benefit
NIH funds prostate cancer technology
Focus Surgery Signed an Agreement With USHIFU For Funding of Prostate Cancer Clinical Trials
Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott
FDA approves Biomatrix clinical
AlphaGene discovers new carcinoembryonic antigen found in prostate
North American Scientific Signs Definitive Agreement to Divest Prostate Brachytherapy Product Line
DakoCytomation granted license for novel prostate cancer markers
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
